INRIG JULA (Chief Medical Officer) sold 1.7% of their position (1.78K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $57.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/5/2026ACC: 0001902368-26-000004
Officer· Chief Medical Officer
Since Jan 2022
-1.78K
Net shares
Net seller
$57.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.78K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.55K
Price / share
$32.11
Trade value
$49.67K
% of position
1.4%
2/4/2026
107.48K→105.94K
Common Stock
Direct
Shares
−232.00
Price / share
$32.85
Trade value
$7.62K
% of position
0.2%
2/4/2026
105.94K→105.71K
Total
Net shares
−1.78K
Net value
-$57.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2026 | S · Sale | −1.55K | $32.11 | $49.67K | 1.4% | 107.48K | 105.94K |
| Common Stock Direct | 2/4/2026 | S · Sale | −232.00 | $32.85 | $7.62K | 0.2% | 105.94K | 105.71K |
| Total | −1.78K | -$57.30K | ||||||
Derivative Transactions0
No derivative transactions reported